233 related articles for article (PubMed ID: 25961436)
1. Clinical Trials of Therapies for Amyotrophic Lateral Sclerosis: One Size Does Not Fit All.
Goutman SA; Feldman EL
JAMA Neurol; 2015 Jul; 72(7):743-4. PubMed ID: 25961436
[No Abstract] [Full Text] [Related]
2. Re: What is next in ALS clinical trials?
Harel NY
Neurology; 2008 Apr; 70(16):1365-6; author reply 1365-6. PubMed ID: 18413594
[No Abstract] [Full Text] [Related]
3. Improving clinical trial outcomes in amyotrophic lateral sclerosis.
Kiernan MC; Vucic S; Talbot K; McDermott CJ; Hardiman O; Shefner JM; Al-Chalabi A; Huynh W; Cudkowicz M; Talman P; Van den Berg LH; Dharmadasa T; Wicks P; Reilly C; Turner MR
Nat Rev Neurol; 2021 Feb; 17(2):104-118. PubMed ID: 33340024
[TBL] [Abstract][Full Text] [Related]
4. Amyotrophic lateral sclerosis.
Owens B
Nature; 2017 Oct; 550(7676):S105. PubMed ID: 29045369
[No Abstract] [Full Text] [Related]
5. DNA Editing for Amyotrophic Lateral Sclerosis: Leading Off First Base.
Cunningham TJ; Fisher E; Fratta P; Gilthorpe JD
CRISPR J; 2020 Apr; 3(2):75-77. PubMed ID: 32315228
[No Abstract] [Full Text] [Related]
6. Clinical highlights.
Borasio GD;
Amyotroph Lateral Scler; 2006 Dec; 7(4):249-51. PubMed ID: 17127565
[No Abstract] [Full Text] [Related]
7. Re: What is next in ALS clinical trials?
Hoke A
Neurology; 2008 Apr; 70(16):1366; author reply 1366-7. PubMed ID: 18413595
[No Abstract] [Full Text] [Related]
8. Ethical considerations in the management of amyotrophic lateral sclerosis.
Eisen A; Krieger C
Prog Neurobiol; 2013 Nov; 110():45-53. PubMed ID: 23735671
[TBL] [Abstract][Full Text] [Related]
9. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
O'Connor DM; Boulis NM
Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
[TBL] [Abstract][Full Text] [Related]
10. Oligonucleotide therapies: the future of amyotrophic lateral sclerosis treatment?
Aoki Y; Douglas AG; Wood MJ
Neurodegener Dis Manag; 2015; 5(2):93-5. PubMed ID: 25894871
[No Abstract] [Full Text] [Related]
11. Meeting report: highlights of the Fifth European ALS Congress.
Petri S; Dengler R
Amyotroph Lateral Scler; 2007 Dec; 8(6):380-2. PubMed ID: 17934896
[No Abstract] [Full Text] [Related]
12. Clinical highlights. 17th International Symposium on ALS/MND Yokohama, Japan, November 30, 2006 through December 2, 2006.
Mitsumoto H
Amyotroph Lateral Scler; 2007 Apr; 8(2):119-20. PubMed ID: 17453641
[No Abstract] [Full Text] [Related]
13. 148th ENMC international workshop on the scientific contributions of the EURALS consortium on amyotrophic lateral sclerosis.
Beghi E; Pupillo E; Zoccolella S;
Neuromuscul Disord; 2009 May; 19(5):379-81. PubMed ID: 19345585
[No Abstract] [Full Text] [Related]
14. Stem cells therapy for ALS.
Mazzini L; Vescovi A; Cantello R; Gelati M; Vercelli A
Expert Opin Biol Ther; 2016; 16(2):187-99. PubMed ID: 26558293
[TBL] [Abstract][Full Text] [Related]
15. Scientific highlights. 17th International Symposium on ALS/MND Yokohama, Japan, November 30, 2006 through December 2, 2006.
Sobue G
Amyotroph Lateral Scler; 2007 Apr; 8(2):121-3. PubMed ID: 17453642
[No Abstract] [Full Text] [Related]
16. Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.
Jiang J; Ravits J
Neurotherapeutics; 2019 Oct; 16(4):1115-1132. PubMed ID: 31667754
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant treatment for amyotrophic lateral sclerosis.
Simpson EP
Lancet Neurol; 2005 May; 4(5):266. PubMed ID: 15847835
[No Abstract] [Full Text] [Related]
18. Has gene therapy for ALS arrived?
Miller TM; Cleveland DW
Nat Med; 2003 Oct; 9(10):1256-7. PubMed ID: 14520369
[No Abstract] [Full Text] [Related]
19. A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?
Xu X; Shen D; Gao Y; Zhou Q; Ni Y; Meng H; Shi H; Le W; Chen S; Chen S
Transl Neurodegener; 2021 Aug; 10(1):29. PubMed ID: 34372914
[TBL] [Abstract][Full Text] [Related]
20. Megaslope, natural course, and historical controls in amyotrophic lateral sclerosis trials.
Conradi S; Ronnevi LO
Adv Neurol; 1995; 68():219-24. PubMed ID: 8787232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
